Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 24, 2023 19:11 ET | Source: ReportLinker

The Global Inflammatory Bowel Disease Market is forecasted to grow by USD 7687.43 mn during 2022-2027, accelerating at a CAGR of 5.77% during the forecast period

New York, July 24, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Inflammatory Bowel Disease Market 2023-2027" -...
July 12, 2023 08:01 ET | Source: CMI

Global Spatial OMICS Market to Reach $547 Million, by 2030 at 9.4% CAGR: Coherent Market Insights

Burlingame, July 12, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global Spatial Omics Market size was valued at $267 million in 2022 and is anticipated to generate $547 million...
June 02, 2023 05:28 ET | Source: OWEN MUMFORD LIMITED

Owen Mumford ontvangt een Red Dot-onderscheiding (Product Design 2023) voor de Aidaptus® Auto-Injector

OXFORD, Engeland, June 02, 2023 (GLOBE NEWSWIRE) -- Owen Mumford heeft tijdens de Red Dot Awards met trots de prestigieuze onderscheiding in ontvangst genomen voor het innovatieve productontwerp van...
May 04, 2023 16:01 ET | Source: Galapagos NV

Galapagos rapporteert financiële resultaten voor het eerste kwartaal van 2023

Voortgang met immunologie en oncologie pijplijn: Eerste patiënten gedoseerd in pivotale fase 3 OLINGUITO-studie met filgotinib in axiale spondyloartritis (AxSpA)Klinische sites geopend voor...
April 25, 2023 07:00 ET | Source: Morphic Therapeutic

Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures

-MORF-057 demonstrates statistically significant reduction of 6.4 points (p=0.002) from baseline at Week 12 in the Robarts Histopathology Index (RHI) Score- -MORF-057 achieves 25.7% clinical...
March 22, 2023 07:00 ET | Source: Vélo Québec

Le prix de la découverte de l’année 2022 du magazine Québec Science est remis à l’équipe de Sébastien Rodrigue, de l’Université de Sherbrooke : des bactéries modifiées à l’assaut des infections intestinales!

MONTRÉAL, 22 mars 2023 (GLOBE NEWSWIRE) -- Depuis maintenant 30 ans, le magazine Québec Science poursuit la tradition : chaque année, un jury de chercheurs et de journalistes sélectionne les 10...
March 16, 2023 11:00 ET | Source: Market.Us

Probiotic Market Size is Expected to Reach USD 131 Bn by 2032; Food and Beverage Industry Drives the Growth

New York, March 16, 2023 (GLOBE NEWSWIRE) -- The global Probiotics Market was valued at around USD 62.4 billion in 2022 and is estimated to be worth approximately USD 131 billion in 2032, growing at...
March 15, 2023 10:46 ET | Source: ReportLinker

Global Inflammatory Bowel Disease (IBD) Therapeutics Market to Reach $32.8 Billion by 2030

New York, March 15, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Inflammatory Bowel Disease (IBD) Therapeutics Industry" -...
February 27, 2023 16:01 ET | Source: Galapagos NV

Galapagos presenteert nieuwe data van langetermijn-uitbreidingsstudie van filgotinib bij colitis ulcerosa op jaarlijks ECCO congres 2023

Zes presentaties tonen Galapagos' betrokkenheid bij inflammatoire darmziekten (IBD)Nieuwe analyses van de fase 3 SELECTION en SELECTION langetermijn-uitbreidingsstudies (LTE) van Jyseleca®...
February 23, 2023 16:01 ET | Source: Galapagos NV

Galapagos kondigt 2022 jaarresultaten en vooruitzichten 2023 aan

2022 belangrijkste en recente gebeurtenissen Dr. Paul Stoffelsi benoemd tot Chief Executive Officer en Voorzitter van de Raad van Bestuur Nieuwe strategische richting geïmplementeerd om innovatie...